E. Martí-Guadaño

Diagnostic and therapeutic approaches in respiratory allergy are different depending on the profile of aeroallergen sensitisation.

I. Dávila, A. Valero, S. Quirce, 2014, Allergologia et immunopathologia.

ESPRINT-15 questionnaire (Spanish version): reference values according to disease severity using both the original and the modified ARIA classifications.

J. Mullol, A. Del Cuvillo, I. Dávila, 2013, Journal of investigational allergology & clinical immunology.

Quality of life in patients with respiratory allergy is influenced by the causative allergen.

I. Dávila, A. Valero, S. Quirce, 2013, Journal of investigational allergology & clinical immunology.

Quality of Life in Patients With Respiratory Allergy Is In uenced by the Causative Allergen

I. Dávila, A. Valero, S. Quirce, 2013 .

Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.

E. Arnáiz, J. Conde, E. Martí-Guadaño, 2005, Journal of investigational allergology & clinical immunology.

Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

J Mullol, J Alonso, J. Mullol, 2010, Allergy.

A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items.

J. Mullol, M. Herdman, A. Del Cuvillo, 2007, The Journal of allergy and clinical immunology.

Rupatadine in allergic rhinitis and chronic urticaria

J. Bousquet, C. Bachert, J. Mullol, 2008, Allergy.

Health‐related quality of life in allergic rhinitis: comparing the short form ESPRINT‐15 and MiniRQLQ questionnaires

J. Mullol, M. Herdman, A. Del Cuvillo, 2007, Allergy.

Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire.

J. Mullol, M. Herdman, J. Orta, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification.

J. Mullol, A. Del Cuvillo, I. Dávila, 2012, Rhinology.